Halozyme Therapeutics, Inc. (HALO)

CIK 1159036 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Halozyme Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001159036-26-000119
Sep 2, 202640001159036-26-000117
Aug 21, 202630001159036-26-000115
Aug 19, 202640001159036-26-000108
Aug 18, 20268-K0001159036-26-000106
Aug 17, 20261440001968582-26-000846
Aug 11, 20261440001950047-26-007986
Aug 11, 202640001662521-26-000002
Aug 10, 20261440001950047-26-007890
Aug 6, 20268-K0001159036-26-000103
Aug 6, 202610-Q0001159036-26-000104
Jul 9, 202640001159036-26-000100
Jul 2, 202640001159036-26-000096
Jul 2, 202640001159036-26-000094
Jul 2, 202640001159036-26-000095
Jul 2, 20268-K0001159036-26-000088
Jun 30, 202640001159036-26-000082
Jun 29, 20261440001950047-26-006595
Jun 15, 202640001159036-26-000077
Jun 9, 202630001159036-26-000076
Jun 3, 202640001159036-26-000074
Jun 2, 202640001159036-26-000072
May 15, 20261440001950047-26-004590
May 13, 202640001159036-26-000070
May 11, 20268-K0001159036-26-000067